HeartSciences Inc. (NASDAQ: HSCSW) Stock Competitors & Peer Comparison
See HSCSW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HSCSW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HSCSW | $0.08 | +105.71% | 209.7K | N/A | -$2,424.55 | N/A |
| ABT | $105.70 | +0.09% | 184.2B | 20.30 | $5.21 | +2.34% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $325.70 | -6.42% | 124.9B | 24.32 | $13.39 | +1.07% |
| MDT | $85.39 | -0.37% | 109.3B | 15.44 | $5.53 | +3.32% |
| BSX | $46.73 | +1.59% | 69.4B | 15.07 | $3.10 | N/A |
| EW | $86.07 | -0.98% | 49.5B | 31.87 | $2.70 | N/A |
| DXCM | $83.45 | +11.95% | 32.2B | 35.82 | $2.33 | N/A |
| RMD | $210.98 | +1.16% | 30.6B | 19.59 | $10.77 | +1.14% |
| PHG | $26.30 | -0.53% | 25.7B | 15.03 | $1.75 | +3.78% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
HSCSW vs ABT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ABT has a market cap of 184.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ABT trades at $105.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ABT's P/E ratio is 20.30. In terms of profitability, HSCSW's ROE is -3.58%, compared to ABT's ROE of +0.11%. Regarding short-term risk, HSCSW is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
HSCSW vs BSX-PA Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, HSCSW's ROE is -3.58%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, HSCSW is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
HSCSW vs SYK Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SYK has a market cap of 124.9B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SYK trades at $325.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SYK's P/E ratio is 24.32. In terms of profitability, HSCSW's ROE is -3.58%, compared to SYK's ROE of +0.16%. Regarding short-term risk, HSCSW is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SYK's competition here
Medtronic plc (NYSE: MDT)
HSCSW vs MDT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, MDT has a market cap of 109.3B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while MDT trades at $85.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas MDT's P/E ratio is 15.44. In terms of profitability, HSCSW's ROE is -3.58%, compared to MDT's ROE of +0.10%. Regarding short-term risk, HSCSW is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
HSCSW vs BSX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BSX has a market cap of 69.4B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BSX trades at $46.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BSX's P/E ratio is 15.07. In terms of profitability, HSCSW's ROE is -3.58%, compared to BSX's ROE of +0.15%. Regarding short-term risk, HSCSW is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
HSCSW vs EW Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, EW has a market cap of 49.5B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while EW trades at $86.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas EW's P/E ratio is 31.87. In terms of profitability, HSCSW's ROE is -3.58%, compared to EW's ROE of +0.10%. Regarding short-term risk, HSCSW is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
HSCSW vs DXCM Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, DXCM has a market cap of 32.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while DXCM trades at $83.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas DXCM's P/E ratio is 35.82. In terms of profitability, HSCSW's ROE is -3.58%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, HSCSW is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
HSCSW vs RMD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, RMD has a market cap of 30.6B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while RMD trades at $210.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas RMD's P/E ratio is 19.59. In terms of profitability, HSCSW's ROE is -3.58%, compared to RMD's ROE of +0.24%. Regarding short-term risk, HSCSW is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
HSCSW vs PHG Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, PHG has a market cap of 25.7B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while PHG trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas PHG's P/E ratio is 15.03. In terms of profitability, HSCSW's ROE is -3.58%, compared to PHG's ROE of +0.10%. Regarding short-term risk, HSCSW is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
HSCSW vs ZBH Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ZBH has a market cap of 18.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ZBH trades at $93.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ZBH's P/E ratio is 11.08. In terms of profitability, HSCSW's ROE is -3.58%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, HSCSW is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
HSCSW vs ABMD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ABMD's P/E ratio is 65.36. In terms of profitability, HSCSW's ROE is -3.58%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, HSCSW is less volatile compared to ABMD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ABMD's competition here
Smith & Nephew plc (NYSE: SNN)
HSCSW vs SNN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SNN has a market cap of 13.3B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SNN trades at $31.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SNN's P/E ratio is 17.02. In terms of profitability, HSCSW's ROE is -3.58%, compared to SNN's ROE of +0.12%. Regarding short-term risk, HSCSW is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SNN's competition here
Penumbra, Inc. (NYSE: PEN)
HSCSW vs PEN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while PEN trades at $321.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas PEN's P/E ratio is 83.87. In terms of profitability, HSCSW's ROE is -3.58%, compared to PEN's ROE of +0.11%. Regarding short-term risk, HSCSW is less volatile compared to PEN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
HSCSW vs SWAV Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SWAV's P/E ratio is 78.76. In terms of profitability, HSCSW's ROE is -3.58%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, HSCSW is less volatile compared to SWAV. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
HSCSW vs ALGN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ALGN trades at $169.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ALGN's P/E ratio is 15.81. In terms of profitability, HSCSW's ROE is -3.58%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, HSCSW is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ALGN's competition here
Insulet Corp. (NASDAQ: PODD)
HSCSW vs PODD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, PODD has a market cap of 11.5B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while PODD trades at $165.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas PODD's P/E ratio is 30.73. In terms of profitability, HSCSW's ROE is -3.58%, compared to PODD's ROE of +0.21%. Regarding short-term risk, HSCSW is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check PODD's competition here
Globus Medical, Inc. (NYSE: GMED)
HSCSW vs GMED Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, GMED has a market cap of 10.6B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while GMED trades at $78.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas GMED's P/E ratio is 17.75. In terms of profitability, HSCSW's ROE is -3.58%, compared to GMED's ROE of +0.13%. Regarding short-term risk, HSCSW is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
HSCSW vs GKOS Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, GKOS has a market cap of 9.8B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while GKOS trades at $166.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas GKOS's P/E ratio is -194.15. In terms of profitability, HSCSW's ROE is -3.58%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, HSCSW is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check GKOS's competition here
Bruker Corporation (NASDAQ: BRKR)
HSCSW vs BRKR Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BRKR has a market cap of 9.6B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BRKR trades at $62.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BRKR's P/E ratio is 34.53. In terms of profitability, HSCSW's ROE is -3.58%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, HSCSW is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BRKR's competition here
Masimo Corporation (NASDAQ: MASI)
HSCSW vs MASI Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas MASI's P/E ratio is 44.43. In terms of profitability, HSCSW's ROE is -3.58%, compared to MASI's ROE of +0.09%. Regarding short-term risk, HSCSW is similarly volatile compared to MASI. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check MASI's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
HSCSW vs BIO-B Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BIO-B has a market cap of 9.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BIO-B trades at $320.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BIO-B's P/E ratio is 95.08. In terms of profitability, HSCSW's ROE is -3.58%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, HSCSW is similarly volatile compared to BIO-B. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
HSCSW vs BIO Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BIO has a market cap of 8.8B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BIO trades at $325.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BIO's P/E ratio is 35.12. In terms of profitability, HSCSW's ROE is -3.58%, compared to BIO's ROE of +0.02%. Regarding short-term risk, HSCSW is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BIO's competition here
Inari Medical, Inc. (NASDAQ: NARI)
HSCSW vs NARI Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas NARI's P/E ratio is -59.24. In terms of profitability, HSCSW's ROE is -3.58%, compared to NARI's ROE of -0.00%. Regarding short-term risk, HSCSW is less volatile compared to NARI. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
HSCSW vs LIVN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while LIVN trades at $80.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas LIVN's P/E ratio is 20.04. In terms of profitability, HSCSW's ROE is -3.58%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, HSCSW is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
HSCSW vs ITGR Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ITGR has a market cap of 4.1B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ITGR trades at $121.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ITGR's P/E ratio is 19.24. In terms of profitability, HSCSW's ROE is -3.58%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, HSCSW is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ITGR's competition here
Haemonetics Corporation (NYSE: HAE)
HSCSW vs HAE Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, HAE has a market cap of 3.9B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while HAE trades at $85.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas HAE's P/E ratio is 17.22. In terms of profitability, HSCSW's ROE is -3.58%, compared to HAE's ROE of +0.11%. Regarding short-term risk, HSCSW is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check HAE's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
HSCSW vs IRTC Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, IRTC has a market cap of 3.9B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while IRTC trades at $117.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas IRTC's P/E ratio is -209.23. In terms of profitability, HSCSW's ROE is -3.58%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, HSCSW is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
HSCSW vs AXNX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas AXNX's P/E ratio is -709.80. In terms of profitability, HSCSW's ROE is -3.58%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, HSCSW is similarly volatile compared to AXNX. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check AXNX's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
HSCSW vs ESTA Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ESTA has a market cap of 2.7B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ESTA trades at $92.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ESTA's P/E ratio is -64.26. In terms of profitability, HSCSW's ROE is -3.58%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, HSCSW is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ESTA's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
HSCSW vs TMDX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, TMDX has a market cap of 2.6B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while TMDX trades at $76.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas TMDX's P/E ratio is 31.23. In terms of profitability, HSCSW's ROE is -3.58%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, HSCSW is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
HSCSW vs AXGN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, AXGN has a market cap of 2.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while AXGN trades at $42.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas AXGN's P/E ratio is 111.08. In terms of profitability, HSCSW's ROE is -3.58%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, HSCSW is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check AXGN's competition here
NuVasive, Inc. (NASDAQ: NUVA)
HSCSW vs NUVA Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas NUVA's P/E ratio is 75.00. In terms of profitability, HSCSW's ROE is -3.58%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, HSCSW is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check NUVA's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
HSCSW vs UFPT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, UFPT has a market cap of 2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while UFPT trades at $254.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas UFPT's P/E ratio is 26.54. In terms of profitability, HSCSW's ROE is -3.58%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, HSCSW is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
HSCSW vs BFLY Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BFLY has a market cap of 1.9B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BFLY trades at $7.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BFLY's P/E ratio is -29.60. In terms of profitability, HSCSW's ROE is -3.58%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, HSCSW is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BFLY's competition here
Novocure Ltd (NASDAQ: NVCR)
HSCSW vs NVCR Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, NVCR has a market cap of 1.7B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while NVCR trades at $14.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas NVCR's P/E ratio is -9.70. In terms of profitability, HSCSW's ROE is -3.58%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, HSCSW is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check NVCR's competition here
Enovis Corporation (NYSE: ENOV)
HSCSW vs ENOV Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ENOV has a market cap of 1.7B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ENOV trades at $29.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ENOV's P/E ratio is 8.63. In terms of profitability, HSCSW's ROE is -3.58%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, HSCSW is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ENOV's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
HSCSW vs ATEC Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ATEC trades at $9.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ATEC's P/E ratio is -86.55. In terms of profitability, HSCSW's ROE is -3.58%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, HSCSW is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ATEC's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
HSCSW vs AHCO Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, AHCO has a market cap of 1.5B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while AHCO trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas AHCO's P/E ratio is 24.27. In terms of profitability, HSCSW's ROE is -3.58%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, HSCSW is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check AHCO's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
HSCSW vs INSP Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, INSP has a market cap of 1.4B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while INSP trades at $50.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas INSP's P/E ratio is 19.43. In terms of profitability, HSCSW's ROE is -3.58%, compared to INSP's ROE of +0.18%. Regarding short-term risk, HSCSW is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
HSCSW vs CNMD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CNMD trades at $46.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CNMD's P/E ratio is 10.21. In terms of profitability, HSCSW's ROE is -3.58%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, HSCSW is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CNMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
HSCSW vs TNDM Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, TNDM has a market cap of 1.3B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while TNDM trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas TNDM's P/E ratio is -17.73. In terms of profitability, HSCSW's ROE is -3.58%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, HSCSW is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check TNDM's competition here
Heska Corporation (NASDAQ: HSKA)
HSCSW vs HSKA Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas HSKA's P/E ratio is -62.49. In terms of profitability, HSCSW's ROE is -3.58%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, HSCSW is similarly volatile compared to HSKA. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check HSKA's competition here
Artivion, Inc. (NYSE: AORT)
HSCSW vs AORT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while AORT trades at $26.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas AORT's P/E ratio is 41.26. In terms of profitability, HSCSW's ROE is -3.58%, compared to AORT's ROE of +0.03%. Regarding short-term risk, HSCSW is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check AORT's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
HSCSW vs IART Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while IART trades at $16.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas IART's P/E ratio is 7.06. In terms of profitability, HSCSW's ROE is -3.58%, compared to IART's ROE of -0.01%. Regarding short-term risk, HSCSW is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
HSCSW vs AVNS Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas AVNS's P/E ratio is 27.77. In terms of profitability, HSCSW's ROE is -3.58%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, HSCSW is less volatile compared to AVNS. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check AVNS's competition here
IRadimed Corporation (NASDAQ: IRMD)
HSCSW vs IRMD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while IRMD trades at $90.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas IRMD's P/E ratio is 45.66. In terms of profitability, HSCSW's ROE is -3.58%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, HSCSW is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check IRMD's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
HSCSW vs SILK Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SILK's P/E ratio is -18.96. In terms of profitability, HSCSW's ROE is -3.58%, compared to SILK's ROE of -0.35%. Regarding short-term risk, HSCSW is less volatile compared to SILK. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
HSCSW vs FNA Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas FNA's P/E ratio is -19.83. In terms of profitability, HSCSW's ROE is -3.58%, compared to FNA's ROE of -0.35%. Regarding short-term risk, HSCSW is less volatile compared to FNA. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check FNA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
HSCSW vs PRCT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while PRCT trades at $18.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas PRCT's P/E ratio is -10.23. In terms of profitability, HSCSW's ROE is -3.58%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, HSCSW is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
HSCSW vs LMRI Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, LMRI has a market cap of 1B. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while LMRI trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas LMRI's P/E ratio is -20.25. In terms of profitability, HSCSW's ROE is -3.58%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, HSCSW is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
HSCSW vs BVS Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BVS has a market cap of 892.2M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BVS trades at $13.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BVS's P/E ratio is 17.56. In terms of profitability, HSCSW's ROE is -3.58%, compared to BVS's ROE of +0.16%. Regarding short-term risk, HSCSW is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
HSCSW vs INMD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, INMD has a market cap of 870.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while INMD trades at $15.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas INMD's P/E ratio is 9.71. In terms of profitability, HSCSW's ROE is -3.58%, compared to INMD's ROE of +0.13%. Regarding short-term risk, HSCSW is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
HSCSW vs CSII Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CSII has a market cap of 844M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CSII's P/E ratio is -20.83. In terms of profitability, HSCSW's ROE is -3.58%, compared to CSII's ROE of -0.14%. Regarding short-term risk, HSCSW is less volatile compared to CSII. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
HSCSW vs SIBN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SIBN has a market cap of 787.6M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SIBN trades at $17.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SIBN's P/E ratio is -45.54. In terms of profitability, HSCSW's ROE is -3.58%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, HSCSW is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SIBN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
HSCSW vs SSII Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SSII has a market cap of 784.5M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SSII trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SSII's P/E ratio is -76.46. In terms of profitability, HSCSW's ROE is -3.58%, compared to SSII's ROE of -0.23%. Regarding short-term risk, HSCSW is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SSII's competition here
CeriBell, Inc. (NASDAQ: CBLL)
HSCSW vs CBLL Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CBLL has a market cap of 671.2M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CBLL trades at $17.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CBLL's P/E ratio is -10.85. In terms of profitability, HSCSW's ROE is -3.58%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, HSCSW is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
HSCSW vs TCMD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, TCMD has a market cap of 635.4M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while TCMD trades at $28.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas TCMD's P/E ratio is 32.01. In terms of profitability, HSCSW's ROE is -3.58%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, HSCSW is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check TCMD's competition here
Surmodics, Inc. (NASDAQ: SRDX)
HSCSW vs SRDX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SRDX's P/E ratio is -34.66. In terms of profitability, HSCSW's ROE is -3.58%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, HSCSW is similarly volatile compared to SRDX. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check SRDX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
HSCSW vs BWAY Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BWAY has a market cap of 597.4M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BWAY trades at $15.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BWAY's P/E ratio is 38.69. In terms of profitability, HSCSW's ROE is -3.58%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, HSCSW is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BWAY's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
HSCSW vs APEN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas APEN's P/E ratio is -9.43. In terms of profitability, HSCSW's ROE is -3.58%, compared to APEN's ROE of -0.85%. Regarding short-term risk, HSCSW is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check APEN's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
HSCSW vs BBNX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BBNX has a market cap of 577.2M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BBNX trades at $12.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BBNX's P/E ratio is -8.50. In terms of profitability, HSCSW's ROE is -3.58%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, HSCSW is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BBNX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
HSCSW vs CTKB Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CTKB has a market cap of 545M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CTKB trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CTKB's P/E ratio is -32.46. In terms of profitability, HSCSW's ROE is -3.58%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, HSCSW is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
HSCSW vs ZIMV Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, HSCSW's ROE is -3.58%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, HSCSW is similarly volatile compared to ZIMV. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check ZIMV's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
HSCSW vs KIDS Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, KIDS has a market cap of 518.6M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while KIDS trades at $20.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas KIDS's P/E ratio is -19.60. In terms of profitability, HSCSW's ROE is -3.58%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, HSCSW is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check KIDS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
HSCSW vs OFIX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, OFIX has a market cap of 477M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while OFIX trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas OFIX's P/E ratio is -48.07. In terms of profitability, HSCSW's ROE is -3.58%, compared to OFIX's ROE of -0.13%. Regarding short-term risk, HSCSW is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check OFIX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
HSCSW vs VREX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, VREX has a market cap of 471.1M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while VREX trades at $11.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas VREX's P/E ratio is 11.78. In terms of profitability, HSCSW's ROE is -3.58%, compared to VREX's ROE of -0.18%. Regarding short-term risk, HSCSW is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check VREX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
HSCSW vs CLPT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CLPT has a market cap of 448M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CLPT trades at $14.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CLPT's P/E ratio is -14.79. In terms of profitability, HSCSW's ROE is -3.58%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, HSCSW is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CLPT's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
HSCSW vs NPCE Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, NPCE has a market cap of 439.5M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while NPCE trades at $12.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas NPCE's P/E ratio is -22.22. In terms of profitability, HSCSW's ROE is -3.58%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, HSCSW is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check NPCE's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
HSCSW vs PACB Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, PACB has a market cap of 434.8M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while PACB trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas PACB's P/E ratio is -2.86. In terms of profitability, HSCSW's ROE is -3.58%, compared to PACB's ROE of -4.88%. Regarding short-term risk, HSCSW is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check PACB's competition here
Cerus Corporation (NASDAQ: CERS)
HSCSW vs CERS Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CERS has a market cap of 430.8M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CERS trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CERS's P/E ratio is -42.91. In terms of profitability, HSCSW's ROE is -3.58%, compared to CERS's ROE of -0.10%. Regarding short-term risk, HSCSW is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CERS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
HSCSW vs DCTH Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, DCTH has a market cap of 421.9M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while DCTH trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas DCTH's P/E ratio is 1222.00. In terms of profitability, HSCSW's ROE is -3.58%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, HSCSW is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check DCTH's competition here
Carlsmed, Inc. (NASDAQ: CARL)
HSCSW vs CARL Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CARL has a market cap of 342.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CARL trades at $12.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CARL's P/E ratio is -5.02. In terms of profitability, HSCSW's ROE is -3.58%, compared to CARL's ROE of -0.62%. Regarding short-term risk, HSCSW is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CARL's competition here
Electromed, Inc. (AMEX: ELMD)
HSCSW vs ELMD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ELMD has a market cap of 336.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ELMD trades at $40.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ELMD's P/E ratio is 34.72. In terms of profitability, HSCSW's ROE is -3.58%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, HSCSW is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ELMD's competition here
CapsoVision, Inc. (NASDAQ: CV)
HSCSW vs CV Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CV has a market cap of 328.8M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CV trades at $6.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CV's P/E ratio is -2.63. In terms of profitability, HSCSW's ROE is -3.58%, compared to CV's ROE of +1.27%. Regarding short-term risk, HSCSW is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
HSCSW vs SMLR Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SMLR's P/E ratio is 3.92. In terms of profitability, HSCSW's ROE is -3.58%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, HSCSW is similarly volatile compared to SMLR. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check SMLR's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
HSCSW vs AVR Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, AVR has a market cap of 288.4M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while AVR trades at $7.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas AVR's P/E ratio is -3.52. In terms of profitability, HSCSW's ROE is -3.58%, compared to AVR's ROE of -1.24%. Regarding short-term risk, HSCSW is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check AVR's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
HSCSW vs SGHT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SGHT has a market cap of 286.2M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SGHT trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SGHT's P/E ratio is -7.41. In terms of profitability, HSCSW's ROE is -3.58%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, HSCSW is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SGHT's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
HSCSW vs TMCI Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, TMCI has a market cap of 279.6M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while TMCI trades at $4.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas TMCI's P/E ratio is -4.59. In terms of profitability, HSCSW's ROE is -3.58%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, HSCSW is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check TMCI's competition here
Profound Medical Corp. (NASDAQ: PROF)
HSCSW vs PROF Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, PROF has a market cap of 268.2M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while PROF trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas PROF's P/E ratio is -5.95. In terms of profitability, HSCSW's ROE is -3.58%, compared to PROF's ROE of -0.70%. Regarding short-term risk, HSCSW is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check PROF's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
HSCSW vs ANIK Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ANIK has a market cap of 256.5M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ANIK trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ANIK's P/E ratio is 39.35. In terms of profitability, HSCSW's ROE is -3.58%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, HSCSW is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check ANIK's competition here
RxSight, Inc. (NASDAQ: RXST)
HSCSW vs RXST Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, RXST has a market cap of 248.8M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while RXST trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas RXST's P/E ratio is -8.35. In terms of profitability, HSCSW's ROE is -3.58%, compared to RXST's ROE of -0.17%. Regarding short-term risk, HSCSW is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
HSCSW vs MGRM Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas MGRM's P/E ratio is -12.00. In terms of profitability, HSCSW's ROE is -3.58%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, HSCSW is similarly volatile compared to MGRM. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
HSCSW vs FOCL Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, FOCL has a market cap of 229.4M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while FOCL trades at $6.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas FOCL's P/E ratio is -7.87. In terms of profitability, HSCSW's ROE is -3.58%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, HSCSW is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
HSCSW vs NVRO Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas NVRO's P/E ratio is -1.91. In terms of profitability, HSCSW's ROE is -3.58%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, HSCSW is less volatile compared to NVRO. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check NVRO's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
HSCSW vs CATX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CATX has a market cap of 223.6M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CATX trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CATX's P/E ratio is -2.05. In terms of profitability, HSCSW's ROE is -3.58%, compared to CATX's ROE of -0.42%. Regarding short-term risk, HSCSW is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CATX's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
HSCSW vs SENS Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, SENS has a market cap of 210.2M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while SENS trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas SENS's P/E ratio is -2.51. In terms of profitability, HSCSW's ROE is -3.58%, compared to SENS's ROE of -1.30%. Regarding short-term risk, HSCSW is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check SENS's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
HSCSW vs BSGM Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas BSGM's P/E ratio is -5.81. In terms of profitability, HSCSW's ROE is -3.58%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, HSCSW is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
HSCSW vs MDGS Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas MDGS's P/E ratio is -0.27. In terms of profitability, HSCSW's ROE is -3.58%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, HSCSW is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check MDGS's competition here
Inogen, Inc. (NASDAQ: INGN)
HSCSW vs INGN Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, INGN has a market cap of 174.6M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while INGN trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas INGN's P/E ratio is -7.09. In terms of profitability, HSCSW's ROE is -3.58%, compared to INGN's ROE of -0.13%. Regarding short-term risk, HSCSW is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check INGN's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
HSCSW vs TLSI Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, TLSI has a market cap of 172.1M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while TLSI trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas TLSI's P/E ratio is -2.70. In terms of profitability, HSCSW's ROE is -3.58%, compared to TLSI's ROE of +1.63%. Regarding short-term risk, HSCSW is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check TLSI's competition here
Quanterix Corporation (NASDAQ: QTRX)
HSCSW vs QTRX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, QTRX has a market cap of 163.9M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while QTRX trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas QTRX's P/E ratio is -2.17. In terms of profitability, HSCSW's ROE is -3.58%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, HSCSW is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check QTRX's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
HSCSW vs QIPT Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas QIPT's P/E ratio is -15.87. In terms of profitability, HSCSW's ROE is -3.58%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, HSCSW is similarly volatile compared to QIPT. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check QIPT's competition here
Neuronetics, Inc. (NASDAQ: STIM)
HSCSW vs STIM Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, STIM has a market cap of 137.8M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while STIM trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas STIM's P/E ratio is -3.67. In terms of profitability, HSCSW's ROE is -3.58%, compared to STIM's ROE of -1.65%. Regarding short-term risk, HSCSW is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check STIM's competition here
CVRx, Inc. (NASDAQ: CVRX)
HSCSW vs CVRX Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, CVRX has a market cap of 137.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while CVRX trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas CVRX's P/E ratio is -2.56. In terms of profitability, HSCSW's ROE is -3.58%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, HSCSW is less volatile compared to CVRX. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check CVRX's competition here
Picard Medical, Inc. (AMEX: PMI)
HSCSW vs PMI Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, PMI has a market cap of 137.1M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while PMI trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas PMI's P/E ratio is -0.07. In terms of profitability, HSCSW's ROE is -3.58%, compared to PMI's ROE of +4.99%. Regarding short-term risk, HSCSW is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check PMI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
HSCSW vs RCEL Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, RCEL has a market cap of 109.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while RCEL trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas RCEL's P/E ratio is -2.80. In terms of profitability, HSCSW's ROE is -3.58%, compared to RCEL's ROE of +3.05%. Regarding short-term risk, HSCSW is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check RCEL's competition here
iCAD, Inc. (NASDAQ: ICAD)
HSCSW vs ICAD Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas ICAD's P/E ratio is -20.37. In terms of profitability, HSCSW's ROE is -3.58%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, HSCSW is similarly volatile compared to ICAD. This indicates similar risk in terms of short-term price fluctuations for HSCSW.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
HSCSW vs HJLI Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas HJLI's P/E ratio is N/A. In terms of profitability, HSCSW's ROE is -3.58%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, HSCSW is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check HJLI's competition here
Rapid Micro Biosystems, Inc. (NASDAQ: RPID)
HSCSW vs RPID Comparison August 2026
HeartSciences Inc. (NASDAQ: HSCSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSCSW stands at 209.7K. In comparison, RPID has a market cap of 96.5M. Regarding current trading prices, HSCSW is priced at $0.08 on the NASDAQ, while RPID trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSCSW currently has a P/E ratio of N/A, whereas RPID's P/E ratio is -1.90. In terms of profitability, HSCSW's ROE is -3.58%, compared to RPID's ROE of -1.32%. Regarding short-term risk, HSCSW is less volatile compared to RPID. This indicates lower risk in terms of short-term price fluctuations for HSCSW.Check RPID's competition here